Pfizer Inc PFE インサイダー取引

Pfizer Inc (PFE) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-03-04	Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer	-826.00	21.99k	Sale to Issuer	26.62	32.93k	-2.45%
2026-02-27	Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer	-655.00	18.11k	Sale to Issuer	27.65	12.04k	-5.16%
2026-02-25	Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer	510.00	17.25k	Derivative Exercise and Retained Stock	33.82	12.70k	4.19%
2026-02-25	Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer	-17.05k	117.57k	Derivative Exercise and Sale	26.92 - 33.82	12.70k	-
2026-02-25	Ms. Payal Sahni BecherChief People Experience Officer & Exec. VP	1.74k	58.81k	Derivative Exercise and Retained Stock	33.82	42.30k	4.29%
2026-02-25	Ms. Payal Sahni BecherChief People Experience Officer & Exec. VP	-55.15k	380.34k	Derivative Exercise and Sale	26.92 - 33.82	42.30k	-
2026-02-25	Mr. Douglas M. LanklerExec. VP & Chief Legal Officer	3.90k	131.83k	Derivative Exercise and Retained Stock	33.82	165.26k	2.42%
2026-02-25	Mr. Douglas M. LanklerExec. VP & Chief Legal Officer	-119.01k	820.79k	Derivative Exercise and Sale	26.92 - 33.82	165.26k	-
2026-02-25	Mr. Michael McDermottExec. VP and Chief Global Supply & Quality Officer	-37.93k	261.35k	Derivative Exercise and Sale	26.92 - 33.82	74.31k	-
2026-02-26	Mr. Michael McDermottExec. VP and Chief Global Supply & Quality Officer	-2.30k	62.36k	Sale to Issuer	27.10	74.31k	-3.00%
2026-02-25	Dr. Albert BourlaChairman of the Board & CEO	16.08k	543.89k	Derivative Exercise and Retained Stock	33.82	394.67k	4.25%
2026-02-25	Dr. Albert BourlaChairman of the Board & CEO	-475.54k	3.28M	Derivative Exercise and Sale	26.92 - 33.82	394.67k	-
2026-02-25	Ms. Lidia L. Fonsecaインサイダー	1.76k	59.66k	Derivative Exercise and Retained Stock	33.82	46.46k	3.95%
2026-02-25	Ms. Lidia L. Fonsecaインサイダー	-55.12k	380.18k	Derivative Exercise and Sale	26.92 - 33.82	46.46k	-
2026-02-25	Dr. Chris BoshoffChief Scientific Officer and President of Research & Development	-6.83k	185.11k	Sale to Issuer	27.09	162.09k	-4.05%
2026-02-23	Dr. Chris BoshoffChief Scientific Officer and President of Research & Development	-816.00	22.08k	Sale to Issuer	27.06	155.54k	-0.52%
2026-02-23	Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer	-419.00	11.34k	Sale to Issuer	27.06	12.19k	-3.32%
2026-01-30	Dr. Chris BoshoffChief Scientific Officer and President of Research & Development	-12.89k	340.73k	Sale to Issuer	26.44	156.34k	-7.62%